ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2048

DDR2 auto-phosphorylation in patients with Warburg-Cinotti syndrome promotes differentiation of fibroblasts into myofibroblasts and expansion of immature B cells with antibody production.

Sang Jin LEE and Yun Jeong Lee, Kyungpook National University School of Medicine, Daegu, Republic of Korea

Meeting: ACR Convergence 2025

Keywords: B-Lymphocyte, Fibroblasts, Dermal

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2015–2051) Miscellaneous Rheumatic & Inflammatory Diseases Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Warburg-Cinotti syndrome (WCS) is a rare connective tissue disorder caused by activating mutations in the DDR2 gene, characterized by progressive corneal neovascularization, keloid-like plaques, and acro-osteolysis. The mechanisms underlying these clinical features remain poorly understood.

Methods: We investigated a family with two WCS patients harboring the DDR2 c.2219A >G (p.Tyr740Cys) variant, a 25-year-old son and his 61-year-old father. Using whole-exome sequencing, single-cell RNA sequencing (scRNA-seq) of skin and peripheral blood mononuclear cells (PBMCs), and protein-level validation, we analyzed the impact of DDR2 activation on fibroblast and immune cells.

Results: Histologic and immunochemical analysis revealed extensive dermal fibrosis and increased smooth muscle actin (SMA)-positive myofibroblasts in WCS skin lesions. scRNA-seq analysis of keloid and normal scar datasets supported the role of DDR2 in promoting fibroblast-to-myofibroblast differentiation. PBMCs analysis from WCS patients showed an expansion of immature/transitional B cells with upregulated PLCG2, PRKCB, and IL7R, along with enhanced B cell receptor (BCR) signaling (Figures 1 and 2). These expanded immature B cells exhibited increased antibody production but reduced diversity of the antibody repertoire, particularly in the older patient. Serum analysis confirmed elevated IgG and free light chain levels. Immunohistochemistry demonstrated increased infiltration of CD68+ macrophages and CD79A+ B cells, with IgG deposition in WCS skin.

Conclusion: Our findings demonstrate that constitutive DDR2 auto-phosphorylation promotes myofibroblast differentiation and expansion of immature B cells, leading to excessive fibrosis and aberrant antibody production. This study advances the understanding of WCS pathogenesis and suggests potential therapeutic targets for its fibrotic and immune related manifestations.

Supporting image 1Figure 1

Supporting image 2Figure 2


Disclosures: S. LEE: None; Y. Lee: None.

To cite this abstract in AMA style:

LEE S, Lee Y. DDR2 auto-phosphorylation in patients with Warburg-Cinotti syndrome promotes differentiation of fibroblasts into myofibroblasts and expansion of immature B cells with antibody production. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/ddr2-auto-phosphorylation-in-patients-with-warburg-cinotti-syndrome-promotes-differentiation-of-fibroblasts-into-myofibroblasts-and-expansion-of-immature-b-cells-with-antibody-production/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ddr2-auto-phosphorylation-in-patients-with-warburg-cinotti-syndrome-promotes-differentiation-of-fibroblasts-into-myofibroblasts-and-expansion-of-immature-b-cells-with-antibody-production/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology